Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 20;1-6.
doi: 10.1007/s00508-020-01672-3. Online ahead of print.

Diabetes and COVID-19 : Disease-Management-People

Free PMC article

Diabetes and COVID-19 : Disease-Management-People

Slobodan Peric et al. Wien Klin Wochenschr. .
Free PMC article


The current pandemic of SARS-CoV‑2 coronavirus disease 2019 (COVID-19) is a particular challenge for diabetes patients. Diabetes mellitus predisposes to a particularly severe course of the disease and doubles the COVID-19 mortality risk due to pulmonary and cardiac involvement. In addition, diabetes patients often suffer from comorbidities which further worsen clinical outcomes. Glycemic control during infectious diseases is often suboptimal, and antidiabetic drugs and insulin therapy have to be adapted accordingly. On the other hand, access of diabetes patients to outpatient clinics are limited during the ongoing season urging alternative treatment options, particularly the implementation of novel telemedicine strategies. Hence, the opportunity of the COVID 19 crisis should be taken to make a significant step forward in the care for diabetes patients.

Keywords: Diabetes complications; Diabetes therapy; SARS-CoV2; Telemedicine; Viral pneumonia.

Conflict of interest statement

S. Peric and T.M. Stulnig declare that they have no competing interests.

Similar articles

See all similar articles


    1. Meo SA, Alhowikan AM, Al-Khlaiwi T, Meo IM, Halepoto DM, Iqbal M, et al. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci. 2020;24(4):2012–2019. - PubMed
    1. University JH. Coronavirus COVID-19 global cases by the center for systems science and engineering (CSSE) at johns Hopkins university 2020. Accessed 6 Apr 2020.
    1. Bundesministerium für Soziales G, Pflege und Konsumentenschutz. Coronavirus, Aktuelle Informationen 2020. Accessed 6 Apr 2020.
    1. Bundesministerium für Soziales G, Pflege und Konsumentenschutz. COVID-19 erkrankte Personen je Bundesland unterteilt in Hospitalisierung und Aufnahme in Intensivstationen sowie Gesamtzahl der Testungen 2020. Accessed 6 Apr 2020.
    1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-coV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 - PubMed

LinkOut - more resources